These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3407588)

  • 1. Lovastatin.
    Feeman WE
    Am Fam Physician; 1988 Aug; 38(2):65-7. PubMed ID: 3407588
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of lovastatin in patients with hyperlipemia following heart transplantation treated with cyclosporine].
    Anguita M; Alonso-Pulpón L; Arizón JM; Vallés F
    Med Clin (Barc); 1994 Oct; 103(12):477-8. PubMed ID: 7996901
    [No Abstract]   [Full Text] [Related]  

  • 3. Lovastatin treatment of hyperlipidemia in kidney transplant recipients on cyclosporine immunosuppression.
    Kandus A; Kovac D; Koselj M; Kveder R; Bren AF
    Transplant Proc; 1994 Oct; 26(5):2642-3. PubMed ID: 7940824
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of lovastatin and bezafibrate on cyclosporine-induced hyperlipidemia in rabbits.
    Hidalgo L; López-Miranda J; Espino A; Alcala J; Blanco J; Prada JL; Rodríguez M; Jiménez-Perepérez JA; Jansen S; Pérez-Jiménez F
    Transplant Proc; 1995 Apr; 27(2):1857-61. PubMed ID: 7725532
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of combined treatment with lovastatin and colestipol on serum lipids and lipoproteins].
    Kłosiewicz-Latoszek L; Nowicka G; Szostak WB
    Wiad Lek; 1993 Aug; 46(15-16):581-5. PubMed ID: 7975581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic use of lovastatin in the treatment of hypercholesterolemia.
    Illingworth DR
    Clin Ther; 1994; 16(1):2-26; discussion 1. PubMed ID: 8205598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three new drugs for hyperlipidemia.
    Conn Med; 2003 May; 67(5):279-81. PubMed ID: 12802842
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipid lowering: myth or therapeutic necessity?].
    Dtsch Med Wochenschr; 1998 Oct; 123(40 Suppl):2-8. PubMed ID: 9793486
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipid-lowering effects of lovastatin in CAPD patients.
    Jacobs RH; Lal SM; Nolph KD
    Adv Perit Dial; 1993; 9():288-90. PubMed ID: 8105945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia].
    Martínez-Castelao A
    Med Clin (Barc); 1995 Nov; 105(18):719. PubMed ID: 8538262
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of patients with dyslipidaemia.
    Mann J; Chisholm A; Crooke M; Jackson R; Neutze J; North D; Swinburn B; White H; Wilcox J
    N Z Med J; 1995 Oct; 108(1010):444. PubMed ID: 7478355
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antihyperlipidemic actions in the treatment of nephropathies].
    Neverov NI; Tareeva IE; Miroshnichenko NG; Stavrovskaia EV
    Ter Arkh; 1995; 67(8):15-7. PubMed ID: 7482321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular pharmacology (VIII). The role of HMG CoA reductase inhibitors in the current treatment of hyperlipidemias].
    Carmena R
    Rev Esp Cardiol; 1995 Jan; 48(1):59-65. PubMed ID: 7878284
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E
    Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bezafibrate and lovastatin decrease the oxidizability of low-density lipoproteins in heart transplant recipients with hyperlidemia.
    Zambrana JL; López-Miranda J; Blanco A; Arizón JM; Jansen S; Paniagua JA; Jimenéz-Perepérez JA; Concha M; Pérez-Jiménez F
    J Heart Lung Transplant; 1998 Dec; 17(12):1213-9. PubMed ID: 9883763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative effectiveness of niacin and lovastatin for treatment of dyslipidemias in a health maintenance organization.
    O'Connor PJ; Rush WA; Trence DL
    J Fam Pract; 1997 May; 44(5):462-7. PubMed ID: 9152263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of and screening for hyperlipidemia.
    Barth JD
    N Engl J Med; 1993 Oct; 329(15):1125; author reply 1127. PubMed ID: 8371741
    [No Abstract]   [Full Text] [Related]  

  • 18. [Correction of hyperlipidemia in patients with gallstones as a method of improving results of extracorporeal lithotripsy].
    Sergeeva NA; Savel'ev SV; Kulikov VM; Zubarev AP; Kolesnikov AL; Dibirov AD; Kostrub VV; Gavrilov SG; Kuznetsov MR; Petukhov VA
    Biull Eksp Biol Med; 1994 Nov; 118(11):555-8. PubMed ID: 7888663
    [No Abstract]   [Full Text] [Related]  

  • 19. Lovastatin versus bezafibrate for hyperlipemia treatment after heart transplantation.
    Hidalgo L; Zambrana JL; Blanco-Molina A; López-Granados A; Concha M; Casares J; Jiménez-Pérez J; López-Miranda J; Pérez-Jiménez F
    J Heart Lung Transplant; 1995; 14(3):461-7. PubMed ID: 7654731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins and fibrates in the management of diabetic dyslipidemia.
    Durrington P
    Diabet Med; 1997 Jul; 14(7):513-6. PubMed ID: 9223386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.